Nomura Holdings Inc. Boosts Stock Position in Cardinal Health, Inc. (NYSE:CAH)

Nomura Holdings Inc. boosted its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 138.7% during the 4th quarter, Holdings Channel.com reports. The firm owned 9,783 shares of the company’s stock after purchasing an additional 5,684 shares during the quarter. Nomura Holdings Inc.’s holdings in Cardinal Health were worth $1,157,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Geode Capital Management LLC increased its holdings in Cardinal Health by 1.9% during the 4th quarter. Geode Capital Management LLC now owns 5,859,132 shares of the company’s stock worth $691,145,000 after purchasing an additional 109,273 shares during the last quarter. Invesco Ltd. increased its holdings in shares of Cardinal Health by 4.6% in the 4th quarter. Invesco Ltd. now owns 3,182,514 shares of the company’s stock valued at $376,396,000 after acquiring an additional 140,368 shares during the last quarter. Marshall Wace LLP increased its holdings in shares of Cardinal Health by 154.6% in the 4th quarter. Marshall Wace LLP now owns 3,151,736 shares of the company’s stock valued at $372,756,000 after acquiring an additional 1,913,892 shares during the last quarter. Northern Trust Corp increased its holdings in shares of Cardinal Health by 16.2% in the 4th quarter. Northern Trust Corp now owns 3,037,849 shares of the company’s stock valued at $359,286,000 after acquiring an additional 422,755 shares during the last quarter. Finally, Amundi increased its holdings in shares of Cardinal Health by 5.5% in the 4th quarter. Amundi now owns 2,116,291 shares of the company’s stock valued at $259,309,000 after acquiring an additional 110,605 shares during the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Stock Performance

NYSE:CAH opened at $154.23 on Monday. Cardinal Health, Inc. has a 1 year low of $93.17 and a 1 year high of $154.68. The stock has a market cap of $36.81 billion, a price-to-earnings ratio of 28.77, a PEG ratio of 1.49 and a beta of 0.66. The business has a fifty day moving average of $137.09 and a 200-day moving average of $127.92.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, May 1st. The company reported $2.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.15 by $0.20. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. The company had revenue of $54.88 billion during the quarter, compared to analysts’ expectations of $55.33 billion. During the same quarter in the prior year, the business posted $2.08 earnings per share. The company’s revenue for the quarter was up .0% compared to the same quarter last year. On average, equities research analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be issued a $0.5107 dividend. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $2.04 annualized dividend and a dividend yield of 1.32%. Cardinal Health’s dividend payout ratio is 31.83%.

Analyst Upgrades and Downgrades

CAH has been the subject of a number of research analyst reports. JPMorgan Chase & Co. boosted their price target on Cardinal Health from $142.00 to $145.00 and gave the company a “neutral” rating in a report on Tuesday, February 4th. Robert W. Baird boosted their price target on Cardinal Health from $156.00 to $170.00 and gave the company an “outperform” rating in a report on Friday, May 2nd. Mizuho boosted their price target on Cardinal Health from $142.00 to $150.00 and gave the company an “outperform” rating in a report on Monday, March 31st. UBS Group upped their price objective on Cardinal Health from $150.00 to $160.00 and gave the stock a “buy” rating in a research note on Tuesday, April 29th. Finally, Argus set a $148.00 price objective on Cardinal Health in a research note on Tuesday, February 4th. Four equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, Cardinal Health presently has a consensus rating of “Moderate Buy” and an average target price of $146.43.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.